When Sex and Fertility Disconnect: The Timing Gap in Modern Reproduction
Today’s posting offers an article by Sonia Gayete-Lafuente, MD, an Associate Physician-Scientist at the Center for Human Reproduction (CHR). The article was partly inspired by a recent publication in a major national newspaper, which asserted that “the female body was not designed for the sex most women are having after age 35.” We assume that this phrase was meant to attract attention; but it - certainly - scientifically can only be called out as incorrect.
However, the publication very clearly pointed out how poorly understood, poorly discussed, and poorly taught female sexual physiology still is when it comes to women above age 35. To say it bluntly, the issue is not what the body was or was not "designed" for, but rather that sexual relationships, contraceptive use, and reproductive intent are now frequently separated across time as society faces delays in the family-building process. As a result, many women experience most of their adult sexual life during periods when pregnancy is not intended, and only later attempt conception at an age when female fecundity has already declined.
With this timing gap being central to understanding contemporary sexual health and infertility patterns in women over age 35 and 40, understanding this divergence is central to contemporary infertility care, as well as women's sexual health.
The CHR’s Editorial Staff
When Sex and Fertility Disconnect: The Timing Gap in Modern Reproduction
By Sonia Gayete-Lafuente, MD, who is an Associate Physician-Scientist at the CHR and at The Foundation for Reproductive Medicine (FRM) and a Visiting Researcher at Rockefeller University in NYC. She is also the Director of Medical Education at the CHR and the FRM and an Associate Editor for Collaboration on the Editorial Board of the CHR. She can be reached through the CHR’s editorial office or directly at sgayete@thechr.com.
The Biology of Female Sex: From Puberty to Menopause
To understand the timing gap between sex and reproduction, we must first appreciate that the female body undergoes profound biological transformations across the reproductive lifespan. These affect not only fertility, but also sexual desire, arousal, pleasure, and orgasm.
The reproductive axis activates during puberty through the hypothalamic-pituitary-gonadal (HPG) axis. Pulsatile secretion of gonadotropin-releasing hormone (GnRH) from the hypothalamus stimulates the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the anterior pituitary. These hormones, in turn, drive ovarian development, gametogenesis, and sex-steroid production.
Adrenarche, the maturation of the hypothalamic-pituitary-adrenal axis, typically begins between ages 6 and 8 with a rise in adrenal androgens such as dehydroepiandrosterone sulfate (DHEA-S). Gonadarche follows between approximately ages 8 and 14, marked by rising ovarian estradiol, breast development, and eventually menarche. These hormonal changes do more than prepare the body for reproduction: they also help establish the neurobiological foundations of sexual desire, arousal, and orgasmic capacity.
Androgen levels in women peak in early adulthood and decline through the reproductive years. Estrogen plays a critical role in female sexual physiology by maintaining genital tissue sensitivity and elasticity, vaginal secretions, pH, and the vaginal microbiome. It also modulates central nervous system pathways, including dopamine and nitric oxide signaling, that contribute to the sexual response. The biological substrate supporting fertility and sexual pleasure is therefore not static; it changes continuously across a woman’s life.
The Physiology of Pleasure and Orgasm
Sexual pleasure and orgasm are not incidental features of reproductive biology. They are complex psychophysiological processes with distinct neuroanatomical and neuroendocrine substratas.
The female sexual response is now understood as nonlinear and circular, rather than as the rigid sequence of desire, arousal, orgasm, and resolution proposed in earlier medical models. Basson’s contemporary model recognizes that desire may be responsive rather than spontaneous, that desire and arousal frequently overlap, and that motivations for sex extend beyond reproduction to include emotional intimacy, pair bonding, and pleasure. Among 2,400 multiethnic women in the Study of Women’s Health Across the Nation (SWAN), 40% reported never or infrequently experiencing spontaneous sexual desire, yet most remained capable of arousal and only 13% expressed dissatisfaction with their sexual experiences.
The clitoris is the principal organ of female sexual pleasure. It consists not only of the external glans and hood, but also of extensive internal structures, including the body, roots, crura, and bulbs. During arousal, smooth-muscle relaxation within the clitoral erectile tissue increases blood flow and engorgement through mechanisms mediated by neurotransmitters, vasoactive peptides, and sex-steroid hormones. Vaginal lubrication results from vascular transudation and glandular secretions, while stimulation of the anterior vaginal wall may contribute to orgasm through the clito-urethro-vaginal complex, rather than through a discrete anatomical “G-spot.”
At the cerebral level, orgasm engages cortical, subcortical, and brainstem regions involved in reward, emotion, memory, motivation, and sensory processing. Dopamine has a central role in sexual motivation, arousal, and reward, while reduced activity in regions involved in behavioral inhibition may contribute to the immersive quality of orgasm. Oxytocin rises during pleasurable sexual activity and remains elevated afterward, contributing to smooth-muscle contractions, emotional bonding, and feelings of well-being. Its interaction with dopamine and endogenous opioid pathways within the brain’s reward centers is believed to support not only sexual pleasure, but also pair bonding and selective social attachment.
These neurobiological systems are not merely accessories to reproduction. They support stress reduction, bonding between lovers, emotional regulation, and subjective well-being. Remarkably, many of these functions persist throughout life, independent of reproductive intent.
How Sexual Pleasure Changes with Age and Menopause
Sexual pleasure can continue across the lifespan, but its physical conditions do not remain constant. Aging and the menopausal transition affect multiple dimensions of sexual function, although the trajectory is considerably morenuanced than a simple decline.
The Melbourne Women’s Midlife Health Project, which prospectively assessed women ages 45 to 55 over eight years, documented an increase in sexual complaints from 42% to 88%, correlated with decreasing estradiol levels. The Global Study of Sexual Attitudes and Behaviors, conducted across 29 countries and including nearly 14,000 women ages 53 to 58, found that lack of sexual interest was the most commonly reported sexual difficulty, followed by difficulty reaching orgasm and poor lubrication.
The mechanisms are multifactorial. Declining estrogen can lead to genitourinary changes, including thinning of the vaginal epithelium, altered collagen, reduced lubrication, and increased tissue resistance, all of which may predispose to dyspareunia. Genital perfusion, engorgement, lubrication, touch perception, and vibratory sensation may also decrease. Reduced estrogen can further attenuate central dopaminergic and nitric oxide, signaling pathways that modulate sexual response.
Even so, orgasmic capacity is generally maintained with age. Some women may require more direct or intense clitoral stimulation, or a longer period of arousal, to reach climax. Reduced pelvic floor muscle tension and changes in uterine contractions may diminish the physical intensity of orgasm or shorten its resolution phase; in some women, uterine contractions may become uncomfortable. Yet validated measures such as the Orgasm Rating Scale and the Bodily Sensations of Orgasm Scale show that the subjective dimensions of orgasm, including pleasure, satisfaction, ecstasy, emotional intimacy, and relaxation, remain broadly comparable across premenopausal, perimenopausal, and postmenopausal women, even when physical sensations change.
Critically, relationship satisfaction, emotional support, self-esteem, optimism, health, and context may predict sexual functioning in midlife and older women more strongly than hormone levels alone. Testosterone has been positively associated with orgasmic function in some studies, but endocrine changes do not fully explain sexual experience once psychosocial variables are considered. Sexual pleasure in later life is therefore neither purely hormonal nor purely psychological; it emerges from the interaction of physiology, relationships, health, and context.
Despite those changes, importantly, sexual life does not end at the boundary of reproductive capacity at all! Women continue to experience desire, arousal, and orgasm well beyond the fertile window, while the biological substrate supporting these experiences shifts.
The Female Body was Never Properly Explained
Despite this complexity, female sexuality has long been treated as mysterious, secondary, or relevant only mainly to reproduction. Many women are never taught the full structure of their sexual anatomy or how female sexual response may change over time.
In that absence of knowledge, normal features of female arousal may be interpreted as personal failure: needing more time, more direct stimulation, greater emotional safety, additional lubrication, clearer communication, or not experiencing spontaneous desire in the way male-centered models have historically defined it. When women and their partners do not understand these differences, the conclusion too often becomes, “She has low libido.”Sometimes, the more accurate explanation is that no one adjusted the conditions her body needs in order to respond!
Unfortunately, a woman may enter midlife with decades of sexual experience, yet she may have received little accurate education about the clitoris, responsive desire, perimenopause, lubrication, pelvic floor function, orgasmic variability, or sexual pain. Her partner may know even less. Because sexual pleasure is often relational, this ignorance has consequences, as it shapes what is requested, assumed, rushed, sometimes pathologized, or - worst case scenario - simply left unspoken.
If a partner interprets slower arousal as rejection, lower spontaneous desire as disinterest, lubrication changes as lack of attraction, or the need for direct clitoral stimulation as “difficulty,” the woman’s body becomes mislabeled. A normal physiological or contextual shift can then become a relationship problem, a confidence problem, or an unnecessary diagnosis.
This is where the claim that women were not “designed” for the sex they are having after 35 becomes useful only if it is turned away from blame. The problem is not that women after 35 are having sex outside of reproduction! The problem is that many women - and their lovers - are navigating sex without understanding female physiology.
When Sexuality and Fertility Begin to Follow Different Timelines
One of the most consequential yet under-recognized changes in modern reproductive health is that sexuality and reproduction no longer occur in parallel. For much of human history, sexual activity, partnership formation, and childbearing tended to occur within a relatively narrow age range. Today, sexual relationships often begin in adolescence or early adulthood, while attempts at conception are increasingly postponed until the mid-to-late thirties or beyond.
This shift is not simply the product of isolated individual choices. It reflects structural and social changes, including longer education, delayed partnership formation, economic pressures, housing costs, changing expectations of relationships and careers, and access to reliable contraception. Many women consequently spend one or two decades experiencing the benefits of sexuality - pleasure, intimacy, attachment, and emotional connection - during years when pregnancy is often neither desired nor planned.
Modern contraception has allowed sexual pleasure and reproduction to be separated more completely than at any previous point in human history - one of the most consequential advances in women’s lives. The paradox is that the same technologies that liberated sexuality from reproduction made the biological constraints of reproduction more visible. Estimates covering 1990 to 2021 suggest that approximately 17.5% of adults worldwide experience infertility during their lifetimes, with delayed childbearing and age-related declines in female fertility contributing substantially to infertility patterns in many regions. Pregnancy could be postponed, but ovarian biology did not move with the social timeline, and that’s why the natural step following long-term contraception has to be fertility preservation counseling!
When Fertility Finally Becomes Relevant, Can Assisted Reproductive Technology Overcome the Timing Gap?
Most individuals do not experience fertility as a continuous biological process. Rather, fertility becomes visible only when pregnancy is desired. In clinical practice, patients often present after months or years of unsuccessful attempts at conception, assuming that timing, stress, or chance may be the principal obstacle. In younger women, this may sometimes be true, but beyond age 35-37, the dominant limiting factor is oocyte age.
Assisted reproductive technologies (ART) - including IVF, embryo cryopreservation, and oocyte freezing - have expanded reproductive options and partially compensated for age-related fertility decline. However, they cannot fully reverse the age-dependent deterioration of oocyte quality with advancing age. The good news is that, clinically, age-related infertility does not occur as an abrupt pathological event but instead represents the delayed recognition of a biological process that has been unfolding silently for years. The key, therefore, is female education and counseling, aiming for recognition of a developing problem, - while still actionable.
Conclusions
Society successfully separated sex from reproduction, but biology did not separate fertility from age. The central issue in contemporary reproductive medicine is that sexual relationships, reproductive intent, and attempts at conception are increasingly decoupled from the biological window of peak female fertility, without sufficiently broad counseling of fertility preservation options alongside extended long-term contraception.
At the same time, medicine and culture have failed to teach women how their sexual physiology changes across the same years in which their reproductive potential declines. Women may feel fully alive sexually and relationally at precisely the stage when fertility is becoming more fragile. That is the modern timing gap: Sexuality may remain active, rewarding, and adaptive across adult life, while reproductive capacity follows a much narrower timetable, which too many women learn too late.
The task of reproductive medicine is therefore not solely to treat age-related infertility in older women. It is also to help all women understand the widening gap between social and biological timelines and do so without reducing sexuality to reproduction or treating physiologic fertility decline as a personal failure. Reproductive medicine cannot eliminate this divergence, but it can help patients recognize it early enough to make informed choices about family building, which may be one of the most important fertility interventions we can offer.
READING LIST
Physiological Aspects of Female Fertility: Role of the Environment, Modern Lifestyle, and Genetics. Hart RJ. Physiological Reviews. 2016;96(3):873-909. doi:10.1152/physrev.00023.2015.
Partial Progress in Sexual and Reproductive Health and Rights: The Influence of Sociocultural, Behavioural, Structural, and Technological Changes on Epidemiological Trends. Grulich AE, Mercer CH, Sturrock B, et al. Lancet (London, England). 2025;406(10515):2100-2118. doi:10.1016/S0140-6736(25)01188-2.
Sexual Desire and Arousal Disorders in Women. Basson R. The New England Journal of Medicine. 2006;354(14):1497-1506. doi:10.1056/NEJMcp050154.
The Neurobiology of Pair Bonding. Young LJ, Wang Z. Nature Neuroscience. 2004;7(10):1048-1054. doi:10.1038/nn1327.
Oxytocin, Dopamine, and Opioid Interactions Underlying Pair Bonding: Highlighting a Potential Role for Microglia. Loth MK, Donaldson ZR. Endocrinology. 2021;162(2):bqaa223. doi:10.1210/endocr/bqaa223.
Brain Activity Unique to Orgasm in Women: An fMRI Analysis. Wise NJ, Frangos E, Komisaruk BR. The Journal of Sexual Medicine. 2017;14(11):1380-1391. doi:10.1016/j.jsxm.2017.08.014.
Optimizing Natural Fertility: A Committee Opinion. Penzias A, Azziz R, Bendikson K, et al. Fertility and Sterility. 2022;117(1):53-63. doi:10.1016/j.fertnstert.2021.10.007.
Assisted Conception in Women of Advanced Maternal Age. Seshadri S, Morris G, Serhal P, Saab W. Best Practice & Research Clinical Obstetrics & Gynaecology. 2021;70:10-20. doi:10.1016/j.bpobgyn.2020.06.012.